31 – 45 of 57
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Novel risk genes for systemic lupus erythematosus predicted by random forest classification
(
- Contribution to journal › Article
-
Mark
Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients
(
- Contribution to journal › Article
- 2016
-
Mark
Case definitions in Swedish register data to identify systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
(
- Contribution to journal › Article
- 2014
-
Mark
Systemic Lupus Erythematosus Prevalence in Sweden in 2010: What Do National Registers Say?
(
- Contribution to journal › Article
- 2013
-
Mark
Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis.
(
- Contribution to journal › Article
-
Mark
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Coronary Heart Disease in Systemic Lupus Erythematosus Is Associated With Interferon Regulatory Factor-8 Gene Variants
(
- Contribution to journal › Article
-
Mark
Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
(
- Contribution to journal › Article
-
Mark
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome
(
- Contribution to journal › Article
- 2012
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?
(
- Contribution to journal › Published meeting abstract
-
Mark
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Association between genetic variants in the tumour necrosis factor/lymphotoxin alpha/lymphotoxin beta locus and primary Sjogren's syndrome in Scandinavian samples
(
- Contribution to journal › Article